The seminar for the Phase III clinical trial protocol of YZJ-4729 Tartrate Injection for postoperative analgesia following abdominal surgery was successfully held.

On November 21, 2024, a seminar on the Phase III clinical trial protocol of YZJ-4729 Tartrate Injection for postoperative analgesia following abdominal surgery was held at Meixi Lake Luxury Collection Hotel in Changsha. Hosted by the Drug Research Institute of YRPG, the seminar invited Professor Ouyang Wen and Professor Wang Saiying from the Third Xiangya Hospital of Central South University, as well as experts from various anesthesia and clinical pharmaceutical research institutions across the country. The seminar aimed to thoroughly discuss and optimize the clinical trial protocol of YZJ-4729 Tartrate Injection to ensure its efficacy and safety in postoperative analgesia for abdominal surgery.